Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03835052 · ClinicalTrials.gov registry record
QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care
A clinical trial, sponsored by Geisinger Clinic.
- Terminated
- Registry status
- 500
- Enrollment target
NCT03835052 is a clinical trial that was terminated before completion, run by Geisinger Clinic. The registered enrollment target is 500 participants.
The verdict
NCT03835052 was terminated before completion, sponsored by Geisinger Clinic.
- TERMINATED
- Registry status
- 500 participants
- Enrollment target
Study Summary
This observational cohort study of patients who received cancer treatment (of any modality) in the last 18 months are evaluated by the use of a validated QOL tool (FACT-GP) and are evaluated via telephone or in person or both. Patients with high-risk for unmet needs or distress as determined by the FACT-GP are referred to an in-person Multidisciplinary Cancer Survivorship Clinic. This is considered standard of care at the investigator's institution and is part of the continuous clinical quality improvement program within the Geisinger Cancer Institute.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03835052
The ClinicalTrials.gov registry entry for NCT03835052 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03835052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03835052 about?
NCT03835052 is a clinical study titled "QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care". This observational cohort study of patients who received cancer treatment (of any modality) in the last 18 months are evaluated by the use of a validated QOL tool (FACT-GP) and are evaluated via telephone or in person or both. Patients with high-risk for unmet needs or distress as determined by the ...
What is the current status of trial NCT03835052?
This trial is currently terminated. The enrollment target is 500 participants. The study started on 2018-10-01. Estimated completion is 2020-03-30.
Who is sponsoring clinical trial NCT03835052?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.